Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Mediwound Ltd MDWD

Healthcare
Mediwound Ltd is an Israel-based biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration. Company's portfolio is focused on next-generation protein-based therapies for burn and wound care and tissue repair and includes products such as, NexoBrid, a concentrate of proteolytic enzymes enriched in... see more

Recent & Breaking News (NDAQ:MDWD)

MediWound Awarded BARDA Contract Valued Up to $112 Million for Development and Procurement of NexoBrid for the U.S.

GlobeNewswire September 30, 2015

MediWound Reports Highlights From the European Burns Association Congress

GlobeNewswire September 29, 2015

MediWound Announces Conference Call and Webcast of "Meet the Experts" Panel Discussion Chaired by BMO Capital Markets at the 16th European Burns Association Congress

GlobeNewswire September 14, 2015

MediWound's NexoBrid(R) Highlighted at the 16th European Burns Association Congress

GlobeNewswire September 10, 2015

MediWound Completes Enrollment in Second Phase 2 Clinical Trial of EscharEx(R) to Treat Chronic and Other Hard-to-Heal Wounds

GlobeNewswire September 1, 2015

MediWound Reports Second Quarter 2015 Financial Results

GlobeNewswire August 3, 2015

MediWound to Host Second Quarter 2015 Financial Results Conference Call on August 4 at 8:30 a.m. ET

GlobeNewswire July 28, 2015

MediWound Approved for First Grant to Support EscharEx(TM) Development Program

GlobeNewswire June 11, 2015

MediWound to Present at Jefferies 2015 Global Healthcare Conference

GlobeNewswire June 1, 2015

MediWound Reports First Quarter 2015 Financial Results

GlobeNewswire May 4, 2015

Poster Presentation Highlighting NexoBrid(TM) Awarded Best-in-Category in Wound Care Practice at the American Burn Association 47th Annual Meeting

GlobeNewswire April 29, 2015

MediWound to Host First Quarter 2015 Financial Results Conference Call on May 4, 2015 at 8:30 a.m.

GlobeNewswire April 23, 2015

MediWound's NexoBrid(R) Highlighted in Presentations at the 2015 American Burn Association 47th Annual Meeting

GlobeNewswire April 21, 2015

MediWound's NexoBrid Highlighted in a Presentation at the International Conference on Minimally Invasive Medicine

GlobeNewswire March 23, 2015

MediWound Reports Fourth Quarter and Year End 2014 Financial Results

Business Wire February 12, 2015

MediWound to Host Fourth Quarter and Year End 2014 Financial Results Conference Call on February 12, 2015 at 8:30 a.m. Eastern Time

GlobeNewswire February 6, 2015

MediWound Ltd. (Nasdaq: MDWD) to Ring The Nasdaq Stock Market Closing Bell

GlobeNewswire February 4, 2015

MediWound to Ring the NASDAQ Stock Market Closing Bell on February 5, 2015 in Recognition of Burn Awareness Week

GlobeNewswire February 4, 2015

MediWound Expands Distribution of NexoBrid to Mexico through Agreement with COVALEO SA

Business Wire January 20, 2015

MediWound to Present at Oppenheimer 25th Annual Healthcare Conference

Business Wire December 9, 2014